brequinar has been researched along with Congenital Zika Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almazan, F; Ávila-Pérez, G; de la Torre, JC; Martinez-Sobrido, L; Morales Vasquez, D; Nogales, A; Park, JG | 1 |
| Adcock, RS; Chu, YK; Chung, DH; Golden, JE | 1 |
2 other study(ies) available for brequinar and Congenital Zika Syndrome
| Article | Year |
|---|---|
Identification of Inhibitors of ZIKV Replication.
Topics: A549 Cells; Animals; Antiviral Agents; Apoptosis; Azauridine; Biphenyl Compounds; Carbamates; Cell Survival; Chlorocebus aethiops; Drug Repositioning; Guillain-Barre Syndrome; Humans; Microcephaly; Phenylurea Compounds; Uganda; Vero Cells; Virus Replication; Zika Virus; Zika Virus Infection | 2020 |
Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.
Topics: Animals; Antiviral Agents; Azauridine; Biphenyl Compounds; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Drug Discovery; High-Throughput Screening Assays; Humans; Ribavirin; Small Molecule Libraries; Vero Cells; Virus Replication; Zika Virus; Zika Virus Infection | 2017 |